Psychedelics and the ‘inner healer’: Myth or mechanism?

IF 4.5 3区 医学 Q1 CLINICAL NEUROLOGY Journal of Psychopharmacology Pub Date : 2024-04-12 DOI:10.1177/02698811241239206
Joseph Peill, Miriam Marguilho, David Erritzoe, Tommaso Barba, Kyle T Greenway, Fernando Rosas, Christopher Timmermann, Robin Carhart-Harris
{"title":"Psychedelics and the ‘inner healer’: Myth or mechanism?","authors":"Joseph Peill, Miriam Marguilho, David Erritzoe, Tommaso Barba, Kyle T Greenway, Fernando Rosas, Christopher Timmermann, Robin Carhart-Harris","doi":"10.1177/02698811241239206","DOIUrl":null,"url":null,"abstract":"Background:Reference to an intrinsic healing mechanism or an ‘inner healer’ is commonplace amongst psychedelic drug-using cultures. The ‘inner healer’ refers to the belief that psychedelic compounds, plants or concoctions have an intrinsically regenerative action on the mind and brain, analogous to intrinsic healing mechanisms within the physical body, for example, after sickness or injury.Aims:Here, we sought to test and critique this idea by devising a single subjective rating item pertaining to perceived ‘inner healing’ effects.Methods:The item was issued to 59 patients after a single high (25 mg, n = 30) or ‘placebo’ (1 mg, n = 29) dose of psilocybin in a double-blind randomised controlled trial of psilocybin for depression.Results:Inner healer scores were higher after the high versus placebo dose of psilocybin ( t = 3.88, p < 0.001). Within the high-dose sub-sample only, inner healer scores predicted improved depressive symptomatology at 2 weeks post-dosing.Conclusions:The principle of activating inner healing mechanisms via psychedelics is scientifically nascent; however, this study takes a positivist and pragmatic step forward, asking whether it warrants further examination.","PeriodicalId":16892,"journal":{"name":"Journal of Psychopharmacology","volume":"38 1","pages":""},"PeriodicalIF":4.5000,"publicationDate":"2024-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/02698811241239206","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background:Reference to an intrinsic healing mechanism or an ‘inner healer’ is commonplace amongst psychedelic drug-using cultures. The ‘inner healer’ refers to the belief that psychedelic compounds, plants or concoctions have an intrinsically regenerative action on the mind and brain, analogous to intrinsic healing mechanisms within the physical body, for example, after sickness or injury.Aims:Here, we sought to test and critique this idea by devising a single subjective rating item pertaining to perceived ‘inner healing’ effects.Methods:The item was issued to 59 patients after a single high (25 mg, n = 30) or ‘placebo’ (1 mg, n = 29) dose of psilocybin in a double-blind randomised controlled trial of psilocybin for depression.Results:Inner healer scores were higher after the high versus placebo dose of psilocybin ( t = 3.88, p < 0.001). Within the high-dose sub-sample only, inner healer scores predicted improved depressive symptomatology at 2 weeks post-dosing.Conclusions:The principle of activating inner healing mechanisms via psychedelics is scientifically nascent; however, this study takes a positivist and pragmatic step forward, asking whether it warrants further examination.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
迷幻药与 "内在治疗师":神话还是机制?
背景:在使用迷幻药的文化中,提到内在治疗机制或 "内在治疗师 "是很常见的。内在治疗者 "指的是迷幻药化合物、植物或混合物对精神和大脑有内在的再生作用,类似于身体内在的治疗机制,例如生病或受伤后的治疗机制。方法:在一项治疗抑郁症的双盲随机对照试验中,59 名患者在服用单次大剂量(25 毫克,n = 30)或 "安慰剂"(1 毫克,n = 29)西洛西宾后接受了该项目。结果:服用大剂量西洛西宾后,内心治愈者得分高于安慰剂(t = 3.88,p < 0.001)。结论:通过迷幻药激活内在治疗机制的原理在科学上尚属新生事物;然而,这项研究迈出了实证主义和实用主义的一步,提出了是否值得进一步研究的问题。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Psychopharmacology
Journal of Psychopharmacology 医学-精神病学
CiteScore
8.60
自引率
4.90%
发文量
126
审稿时长
3-8 weeks
期刊介绍: The Journal of Psychopharmacology is a fully peer-reviewed, international journal that publishes original research and review articles on preclinical and clinical aspects of psychopharmacology. The journal provides an essential forum for researchers and practicing clinicians on the effects of drugs on animal and human behavior, and the mechanisms underlying these effects. The Journal of Psychopharmacology is truly international in scope and readership.
期刊最新文献
High-dose Vitamin-B6 reduces sensory over-responsivity. Clinical effects of CYP2D6 phenoconversion in patients with psychosis. Influence of panic disorder and paroxetine on brain functional hubs in drug-free patients. Aspirin may be more suitable for patients with major depression: Evidence from two-sample Mendelian randomization analysis. Optimizing the individual dosing of paroxetine in major depressive disorder with therapeutic drug monitoring.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1